When considering all CLL patients, we found that SLC7A5 + URAHP + FAM166A/CNTNAP2 + HOMER3 + MACC1 (AUC 80.33%) is the best combination of genes considered for predicting relapse events within 15–18 months. The gene discussed is SLC7A5; the disease is B-cell chronic lymphocytic leukemia.